Stocks
Receptos, Inc.RCPT
YHDHealthcareBiotechnology
A biotechnology developer focused on therapies targeting immune-mediated diseases, best known for advancing sphingosine‑1‑phosphate receptor modulators for conditions such as multiple sclerosis and inflammatory bowel disease. Its lead drug candidate, ozanimod, drew significant investor attention due...
Congressional Interest in Receptos, Inc. (RCPT)
1 member of Congress has disclosed 2 trades in Receptos, Inc. (RCPT), a Healthcare company. The buy/sell breakdown shows 1 purchase versus 1 sale. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
2
Unique Politicians
1
Buys
1
Sells
1
Who in Congress Is Trading RCPT?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2015-05-27 | Thomas MacArthur | sell | $1K – $15K |
| 2015-05-26 | Thomas MacArthur | buy | $1K – $15K |